Matsubara, Japan

Takafumi Ishii

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fujimoto Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takafumi Ishii. Retrieved from https://idiyas.com/inventor/takafumi-ishii-tl9ltjs2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takafumi Ishii: Innovator in Thiophene Derivatives

Introduction

Takafumi Ishii is a notable inventor based in Matsubara, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on thiophene derivatives. His innovative approach has led to advancements in treatments for various medical conditions.

Latest Patents

Ishii holds a patent for a thiophene derivative, which is represented by a specific formula. This invention is particularly noteworthy for its TNF-α production suppressive activity and its ability to inhibit hematologic cancer cell proliferation. The thiophene derivative is useful in treating rheumatoid arthritis, Crohn's disease, ulcerative colitis, and hematologic cancer. He has 1 patent to his name.

Career Highlights

Ishii is associated with Fujimoto Co., Ltd., where he has been able to apply his expertise in developing innovative pharmaceutical solutions. His work has garnered attention in the scientific community for its potential impact on patient care.

Collaborations

Ishii has collaborated with notable colleagues, including Mayumi Watanabe and Yasuhiko Mizutani. These partnerships have contributed to the advancement of research and development in their field.

Conclusion

Takafumi Ishii's contributions to the field of medicinal chemistry, particularly through his patent on thiophene derivatives, highlight his role as an innovator. His work continues to pave the way for new treatments in various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…